Ilyaev Benjamin, Muminiy Sabina N, Borukh Emmanuella, Izrailov Emmanuel, Musheyev Yakubmiyer, Ilyayeva Stella
Medicine, Hofstra University, Hempstead, USA.
Medicine, St. Francis College, New York City, USA.
Cureus. 2023 Jun 23;15(6):e40851. doi: 10.7759/cureus.40851. eCollection 2023 Jun.
Thyroiditis should be in the differential for hyperthyroidism when thyroid-stimulating hormone (TSH) is suppressed and T3/T4 levels are elevated. Suspicion of hyperthyroidism is further increased when the patient can exhibit symptoms such as weight loss, anxiety, feeling feverish, tremors, shaking, and sweating. Hyperthyroidism is generally classified as being overt or subclinical. In the following case, the patient had overt hyperthyroidism which is considered more severe than subclinical hyperthyroidism. Coronavirus disease is not typically associated with thyroiditis; however, in this case, the patient's disorder was accidentally found on her blood results which were originally taken due to her coronavirus disease 2019 (COVID-19) diagnosis. In this case study, we present a 30-year-old female patient, with suspicions of COVID-19-induced hyperthyroidism found incidentally on her blood panel. An original diagnosis of thyroiditis was made prior to the visualization of increased release of thyroid hormone. A sonogram was done, and a follow-up blood panel was ordered, confirming the patient's diagnosis of hyperthyroidism post COVID-19 recovery.
当促甲状腺激素（TSH）被抑制且T3/T4水平升高时，甲状腺炎应列入甲状腺功能亢进的鉴别诊断范围。当患者出现体重减轻、焦虑、发热感、震颤、发抖和出汗等症状时，对甲状腺功能亢进的怀疑会进一步增加。甲状腺功能亢进通常分为显性或亚临床型。在以下病例中，患者患有显性甲状腺功能亢进，这被认为比亚临床甲状腺功能亢进更为严重。冠状病毒病通常与甲状腺炎无关；然而，在该病例中，患者的病症是在其因2019冠状病毒病（COVID-19）诊断而最初进行的血液检查结果中意外发现的。在本病例研究中，我们介绍了一名30岁女性患者，其在血液检查中意外发现疑似COVID-19诱发的甲状腺功能亢进。在甲状腺激素释放增加显现之前，最初诊断为甲状腺炎。进行了超声检查，并安排了后续血液检查，证实患者在COVID-19康复后被诊断为甲状腺功能亢进。
